Ark Therapeutics Group Plc

Ark Therapeutics Group Plc

Sector: Commercial Physical And Biological Research Region: United Kingdom

: | London Stock Exchange: AKT

Similar to: Medivir AB, Exelixis, Inc., Advanced Cell Technology, Inc.

Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.

News & Analysis

You may also be interested in: